Scaling a model that was not working yet: the $40 million lesson from Brave Care

Brave Care started with two weekends. Darius Monsef's child split their chin at a bike park and was stitched up by a paediatric urgent care doctor. The following weekend his one-year-old had croup. His wife was away both times. He met the doctor for coffee, and by 2019 they were building a company together.

It became his second Y Combinator company. It raised $6 million before Demo Day, so he skipped Demo Day entirely. Over five years it raised more than $40 million, opened five clinics, employed more than 100 people and treated 50,000 sick and injured children. Then it shut down.

The number that showed it

The model assumed $199 in average revenue per visit. Late in the company's life, someone told him the real figure was closer to $138.

In a clinic business that gap is not a rounding error. Darius points out that a model swings by millions on the difference between $140 and $160 a visit. A $61 shortfall against plan, applied across five clinics, means the economics were never going to work at the scale they had already built to.

By the end the company was losing a million dollars a month with more than 100 employees on payroll.

Why it took so long to see

American healthcare made the maths unusually hard to pin down. Revenue varies by billing code, and the business contracted with multiple insurance carriers. Every time Brave Care hired a clinician, it had to recontract with all of them, and each contracting cycle took six to nine months.

So the true revenue per visit was a moving target that lagged months behind every hiring decision. The company kept opening clinics while the number it most needed was still resolving.

Money is not proof

The trap Darius describes is one that funding makes worse rather than better. A large raise reads as validation, and validation encourages expansion, and expansion multiplies whatever is broken in the underlying model.

Brave Care opened five clinics before one clinic was reliably profitable. Each new site copied the same economics and added burn.

What it cost

The Series B was not going to happen. Shutting down meant losing investors' money and letting go of more than 100 people. His co-founder, a medical provider who had left clinical practice for the company, is still angry with him, and Darius does not argue with that.

He also counts what worked. Fifty thousand children were treated. He took his own kids there 32 times as a parent rather than as the chief executive. A friend who is a Y Combinator partner offers a test for whether a company should keep going: would people be genuinely upset if you shut it down. For Brave Care, parents were.

The lesson he takes from it is narrower than the story. Prove the unit works, then repeat it. The order matters more than the funding.